Gurugram: Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, today announced that it has signed a licensing deal with Oravax Medical Inc. for development and commercialization in India, of its virus-like-particle COVID-19 vaccine technology. Premas Biotech signs licensing deal for virus-like particle (VLP) injectable vaccine technology for COVID-19, with Oravax for commercialization in […]